Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label California. Show all posts
Showing posts with label California. Show all posts

Wednesday, January 4, 2017

Youthful Brains in Older Adults: Preserved Neuroanatomy in the Default Mode and Salience Networks Contributes to Youthful Memory in Superaging

What protocol does your doctor have for increasing your cortical thickness?  Not having one is grounds for calling the hospital president and asking about the competence of the stroke department. What are the departments goals and objectives? Hopefully it is about getting survivors to 100% recovery, not run as a profit center.

Youthful Brains in Older Adults: Preserved Neuroanatomy in the Default Mode and Salience Networks Contributes to Youthful Memory in Superaging

Felicia W. Sun, Michael R. Stepanovic, Joseph Andreano, Lisa Feldman Barrett, Alexandra Touroutoglou and Bradford C. Dickerson

Tuesday, November 19, 2013

Kaiser Permanente Receives Honor for Outstanding Heart Attack, Stroke Care

The Right Care initiative in California needs to revamp its definition of what is considered good stroke care. If you want to prevent disability from stroke you need to stop the neuronal cascade of death. Does no one have 2 brain cells to rub together?
http://news.gnom.es/pr/kaiser-permanente-receives-honor-for-outstanding-heart-attack-stroke-care
Launched in 2008, the Right Care Initiative is a public-private collaborative effort focused on preventing premature disability and death from heart attacks, strokes and diabetic complications.
CONTACTMark CampsMark.V.Camps@kp.org
510-529-1854
SOURCE Kaiser Permanente

http://www.kaiserpermanente.org

Friday, May 25, 2012

California stem-cell agency shifts toward clinical work

At least we have one state that is working in the right direction. I have no idea how to influence this agency to work on neurons. California readers, some help here.
http://blogs.nature.com/news/2012/05/california-stem-cell-agency-shifts-toward-clinical-work.html
I only copied the first 4 paragraphs.
The California Institute of Regenerative Medicine (CIRM) voted on 24 May to accept a new strategic plan which shrinks or eliminates support for basic research, facilities and training, while funneling more of its funds toward clinical development. “The first stage of CIRM was really exploring the field,” said Ellen Feigal, senior vice president of R&D. “The next five years should be one of more focus.” By July 2013, the agency hopes to have two programmes approved for clinical trials in the United States.
During the past five years, nearly half of the approximately $1.3 billion awarded by the agency went toward building new research facilities and training and career development. Looking ahead, of the approximately $840 million to be awarded  over the next five years, about three fifths is slotted to go toward development research,  preparing stem cell-based therapeutics for clinical testing, with much of the rest devoted to translational and basic research. (An additional $650 million has been approved but not awarded; allocation is roughly an average between previously awarded funds and future plans.)
No one spoke during a call for comments from the general public, and the plan was approved by a voice vote with no objections. Board member Jeff Sheehy voiced concerns about cutting off training and basic research. CIRM president Alan Trounson and Ellen Feigal said that the exact allocations could be determined at future meetings. There was general acknowledgement that difficult funding decisions are ahead. “We are now in the realm of trade-offs,” said Sheehy.
Also today, CIRM announced $69 million of grants for translational research. “With these new awards, the agency now has 52 projects in 33 diseases at varying stages of working toward clinical trials,” said Jonathan Thomas, governing board chair, said in a statement.